Analyzing the 29 BRCA1-methylation-positive breast cancer patients separately revealed similar results to those of the overall group of BC patients, where the expression of miR-155-5p was significantly higher in patients compared to controls (p = 0.004) (Figure 3D). This evidence concerns the gene BRCA1 and breast carcinoma.